The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa

ME Falagas, PK Koletsi… - Journal of medical …, 2006 - microbiologyresearch.org
… the 42 identified studies that reported on MDR or PDR P. … various antimicrobial agents to
define the term MDR or PDR A. … an effort would probably reveal more problems in the use of the …

[PDF][PDF] Challenge of intensive care unit-acquired infections and Acinetobacter baumannii in developing countries

A Ulu-Kilic, S Ahmed, E Alp, M Doğanay - OA Critical Care, 2013 - researchgate.net
… declined due to stagnation in novel antimicrobial agents … and rifampicin were studied to
find a solution to the therapeutic … nosocomial Acinetobacter and Pseudomonas aeruginosa

Infectious Diseases Society of America guidance on the treatment of AmpC β-lactamase–producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii …

PD Tamma, SL Aitken, RA Bonomo… - Clinical Infectious …, 2022 - academic.oup.com
Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-… has been identified and
antibiotic susceptibility results are … These organisms pose different management challenges for …

[HTML][HTML] Treatment Options for Carbapenem-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Infections

JA Viehman, MH Nguyen, Y Doi - Drugs, 2014 - Springer
challenge due to extensively-resistant nosocomial infections … and effective antimicrobial
agents that can be used for treatment. … pneumoniae and Pseudomonas aeruginosa as well as A. …

[HTML][HTML] Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens

K Lee, D Yong, SH Jeong, Y Chong - Yonsei medical journal, 2011 - ncbi.nlm.nih.gov
… soon after introduction of new antimicrobial agents (Table 1). … difficult to find new ones. Now,
we know that emergence of … impact of Acinetobacter baumannii colonization and infection at …

Acinetobacter baumannii: a universal threat to public health?

H Giamarellou, A Antoniadou… - … of antimicrobial agents, 2008 - Elsevier
… resistant to carbapenems, aminoglycosides and fluoroquinolones presents a challenge to the
… , as also identified by the AATF, are A. baumannii and Pseudomonas aeruginosa. Despite …

[HTML][HTML] Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment

ET Piperaki, LS Tzouvelekis, V Miriagou… - … and Infection, 2019 - Elsevier
Difficulties in treating CRAB infections stem from a … parameters of relevant antimicrobial
agents, a critical appraisal of … efficient in detecting differences between treatment groups [86]. …

Facing the challenges of multidrug-resistant Acinetobacter baumannii: progress and prospects in the vaccine development

NA Mat Rahim, HY Lee, U Strych… - Human vaccines & …, 2021 - Taylor & Francis
baumannii were identified and evaluated as vaccine antigen … at least three classes of
antimicrobial agents, viz. penicillins … against bacterial challenge in a rat soft tissue infection model. …

Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections

JP Horcajada, M Montero, A Oliver, L Sorlí… - Clinical microbiology …, 2019 - Am Soc Microbiol
… strains have recently become issues of public health concern… , the challenge of detecting
transferable β-lactamases in P. … reported for infections caused by Acinetobacter baumannii, …

Prevalence of Carbapenem-Resistant Gram-Negative Infections in the United States Predominated by Acinetobacter baumannii and Pseudomonas aeruginosa

B Cai, R Echols, G Magee… - … forum infectious …, 2017 - academic.oup.com
identified, and antimicrobial drugs used for susceptibility testing along with the method,
result, and interpretation of antibiotic … This further highlights the treatment challenges faced by …